Production and characterization of biologically active recombinant human nerve growth factor

Gordon Bruce, Gerhard Heinrich

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Nerve growth factor (NGF) is required for the differentiation and maintenance of sympathetic and sensory neurons. In animal models, NGF prevents the death of septal and basal forebrain cholinergic neurons deprived of endogenous NGF, suggesting that NGF may be of benefit in neurodegenerative diseases of humans. However, little is known about NGF in human brain, partly because a sensitive assay for hNGF has been lacking. As a first step toward developing the tools for the study of NGF in humans, recombinant human NGF (rhNGF) was produced by expressing exon 4 of the human NGF gene in COS cells. The expression vector is driven by the adenovirus major late promoter and contains an SV40 origin of replication. NGF was secreted by transiently transfected cells. Conditioned medium was assayed with an enzyme immunoassay (EIA) that utilizes a monoclonal antibody (clone 27/21) against mouse β-NGF, and contained 15 ng/ml of rhNGF. The rhNGF migrated as a dimer of 26-29 Kd on a gel permeation chromatography column, and stimulated neurite outgrowth and neuropeptide Y mRNA levels in PC12 cells. With optimization, the described expression system is capable of providing sufficient hNGF for research and therapeutic purposes.

Original languageEnglish (US)
Pages (from-to)89-94
Number of pages6
JournalNeurobiology of Aging
Volume10
Issue number1
DOIs
StatePublished - 1989

Fingerprint

Nerve Growth Factor
Therapeutic Human Experimentation
Cholinergic Neurons
Replication Origin
COS Cells
Neuropeptide Y
PC12 Cells
Sensory Receptor Cells
Conditioned Culture Medium
Immunoenzyme Techniques
Adenoviridae
Neurodegenerative Diseases
Gel Chromatography
Exons
Animal Models
Clone Cells
Monoclonal Antibodies
Maintenance

Keywords

  • Alzheimer's disease
  • Biologically active recombinant human NGF
  • Central cholinergic neurons
  • Expression vector
  • Human nerve growth factor
  • Human nerve growth factor gene
  • Mammalian expression system

ASJC Scopus subject areas

  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology
  • Clinical Neurology

Cite this

Production and characterization of biologically active recombinant human nerve growth factor. / Bruce, Gordon; Heinrich, Gerhard.

In: Neurobiology of Aging, Vol. 10, No. 1, 1989, p. 89-94.

Research output: Contribution to journalArticle

@article{7b9e80b67b114663b215be36bc3ca86b,
title = "Production and characterization of biologically active recombinant human nerve growth factor",
abstract = "Nerve growth factor (NGF) is required for the differentiation and maintenance of sympathetic and sensory neurons. In animal models, NGF prevents the death of septal and basal forebrain cholinergic neurons deprived of endogenous NGF, suggesting that NGF may be of benefit in neurodegenerative diseases of humans. However, little is known about NGF in human brain, partly because a sensitive assay for hNGF has been lacking. As a first step toward developing the tools for the study of NGF in humans, recombinant human NGF (rhNGF) was produced by expressing exon 4 of the human NGF gene in COS cells. The expression vector is driven by the adenovirus major late promoter and contains an SV40 origin of replication. NGF was secreted by transiently transfected cells. Conditioned medium was assayed with an enzyme immunoassay (EIA) that utilizes a monoclonal antibody (clone 27/21) against mouse β-NGF, and contained 15 ng/ml of rhNGF. The rhNGF migrated as a dimer of 26-29 Kd on a gel permeation chromatography column, and stimulated neurite outgrowth and neuropeptide Y mRNA levels in PC12 cells. With optimization, the described expression system is capable of providing sufficient hNGF for research and therapeutic purposes.",
keywords = "Alzheimer's disease, Biologically active recombinant human NGF, Central cholinergic neurons, Expression vector, Human nerve growth factor, Human nerve growth factor gene, Mammalian expression system",
author = "Gordon Bruce and Gerhard Heinrich",
year = "1989",
doi = "10.1016/S0197-4580(89)80015-6",
language = "English (US)",
volume = "10",
pages = "89--94",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Production and characterization of biologically active recombinant human nerve growth factor

AU - Bruce, Gordon

AU - Heinrich, Gerhard

PY - 1989

Y1 - 1989

N2 - Nerve growth factor (NGF) is required for the differentiation and maintenance of sympathetic and sensory neurons. In animal models, NGF prevents the death of septal and basal forebrain cholinergic neurons deprived of endogenous NGF, suggesting that NGF may be of benefit in neurodegenerative diseases of humans. However, little is known about NGF in human brain, partly because a sensitive assay for hNGF has been lacking. As a first step toward developing the tools for the study of NGF in humans, recombinant human NGF (rhNGF) was produced by expressing exon 4 of the human NGF gene in COS cells. The expression vector is driven by the adenovirus major late promoter and contains an SV40 origin of replication. NGF was secreted by transiently transfected cells. Conditioned medium was assayed with an enzyme immunoassay (EIA) that utilizes a monoclonal antibody (clone 27/21) against mouse β-NGF, and contained 15 ng/ml of rhNGF. The rhNGF migrated as a dimer of 26-29 Kd on a gel permeation chromatography column, and stimulated neurite outgrowth and neuropeptide Y mRNA levels in PC12 cells. With optimization, the described expression system is capable of providing sufficient hNGF for research and therapeutic purposes.

AB - Nerve growth factor (NGF) is required for the differentiation and maintenance of sympathetic and sensory neurons. In animal models, NGF prevents the death of septal and basal forebrain cholinergic neurons deprived of endogenous NGF, suggesting that NGF may be of benefit in neurodegenerative diseases of humans. However, little is known about NGF in human brain, partly because a sensitive assay for hNGF has been lacking. As a first step toward developing the tools for the study of NGF in humans, recombinant human NGF (rhNGF) was produced by expressing exon 4 of the human NGF gene in COS cells. The expression vector is driven by the adenovirus major late promoter and contains an SV40 origin of replication. NGF was secreted by transiently transfected cells. Conditioned medium was assayed with an enzyme immunoassay (EIA) that utilizes a monoclonal antibody (clone 27/21) against mouse β-NGF, and contained 15 ng/ml of rhNGF. The rhNGF migrated as a dimer of 26-29 Kd on a gel permeation chromatography column, and stimulated neurite outgrowth and neuropeptide Y mRNA levels in PC12 cells. With optimization, the described expression system is capable of providing sufficient hNGF for research and therapeutic purposes.

KW - Alzheimer's disease

KW - Biologically active recombinant human NGF

KW - Central cholinergic neurons

KW - Expression vector

KW - Human nerve growth factor

KW - Human nerve growth factor gene

KW - Mammalian expression system

UR - http://www.scopus.com/inward/record.url?scp=0024317164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024317164&partnerID=8YFLogxK

U2 - 10.1016/S0197-4580(89)80015-6

DO - 10.1016/S0197-4580(89)80015-6

M3 - Article

C2 - 2666869

AN - SCOPUS:0024317164

VL - 10

SP - 89

EP - 94

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 1

ER -